These outcomes, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the thought of focusing on ACKR3 as a unique technique to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders. In response to this concern, https://fank405ctj0.p2blogs.com/profile